Global Diabetic Kidney Disease Market Report 2024

Diabetic Kidney Disease Global Market Report 2024 – By Type (Type 1 Diabetes, Type 2 Diabetes), By Treatment (Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments), By End User (Hospitals, Homecare, Specialty Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Diabetic Kidney Disease Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Diabetic Kidney Disease Market Definition And Segments

Diabetic kidney disease refers to a type of renal disease driven by complications of diabetes that occurs when high levels of blood sugar cause damage to the kidneys. The blood vessels in the kidneys can become affected by high blood glucose, which ultimately reduces their functionality.

The main types of diabetic kidney disease are type 1 diabetes and type 2 diabetes. Type 1 diabetes refers to a chronic autoimmune condition in which the pancreas produces little or no insulin, leading to high blood sugar levels that cause harm to the nephrons and renal blood vessels and requiring daily insulin injections to manage blood sugar levels. They are treated by angiotensin receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, antioxidant inflammation modulators, calcium channel blockers, and other treatments in medical facilities including hospitals, homecare, specialty centers, and others.

The diabetic kidney disease market covered in this report is segmented –

1) By Type: Type 1 Diabetes, Type 2 Diabetes

2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments

3) By End User: Hospitals, Homecare, Specialty Centers, Other End Users

The diabetic kidney disease market size has grown strongly in recent years. It will grow from $2.51 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to early understanding of diabetes complications, advancements in diagnostic techniques, development of ace inhibitors and arbs, clinical trials and treatment protocols, guidelines and disease management protocols.

The diabetic kidney disease market size is expected to see strong growth in the next few years. It will grow to $3.29 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to personalized medicine and biomarker development, rising global diabetes incidence, focus on disease modification therapies, telehealth and remote care, healthcare policy and reimbursement changes. Major trends in the forecast period include advancements in renal replacement therapies, precision medicine approach, focus on early detection and diagnosis, therapeutic advancements, rise in comorbidities management.

The Soaring Prevalence Of Chronic Kidney Disease Propelling Growth In The Diabetic Kidney Disease Market

The rising prevalence of chronic kidney disease is expected to propel the growth of the diabetic kidney disease market. Chronic kidney disease (CKD) refers to a long-term condition that results in the loss of kidney function over time causing a number of complications such as high blood pressure, anemia, and bone diseases. The treatment of chronic kidney diseases requires diagnostic and treatment options, ultimately fueling the growth of the diabetic kidney disease market. For instance, in 2021, according to the report published by the Centers for Disease Control and Prevention (CDC), a US-based public health agency, more than 37 million people were estimated to have chronic kidney disease (CKD) in the USA. Furthermore, CKD is more common in adults 65 and older, with approximately 38% of older adults suffering from some form of kidney damage. Therefore, the rising prevalence of chronic kidney disease is driving the growth of the diabetic kidney disease market going forward.

The Impact Of Escalating Healthcare Expenditure On The Diabetic Kidney Disease Market

The increasing healthcare expenditure is expected to boost the growth of the diabetic kidney disease market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare-related goods and services within a specific period, typically on a national or institutional level. Elevated healthcare spending facilitates the uptake of state-of-the-art diagnostic technologies, allowing for early and precise detection of diabetic kidney disease and enabling prompt intervention and treatment. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, the projected growth indicates that, on average, national health spending is expected to increase by 5.1% annually between 2021 and 2030, reaching a total of nearly $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending is going to rise at a 7.2% annual pace while Medicaid spending will rise at a 5.6% annual rate. Therefore, the increasing healthcare expenditure is driving the growth of the diabetic kidney disease market.

Major companies operating in the diabetic kidney disease market report are AstraZeneca PLC, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson Pvt. Ltd., Eli Lilly and Company, Allergan Inc., Endo International Inc., GlaxoSmithKline PLC, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Fresenius Kabi AG, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd. .

Technological Advancements Reshaping The Landscape Of The Diabetic Kidney Disease Market

Technological advancements are a key trend gaining popularity in the diabetic kidney disease market. Companies operating in the diabetic kidney disease market are adopting new technologies to sustain their position in the market. For instance, in August 2022, Bloom Diagnostics, a US-based diagnostics and healthcare devices organization, launched the Bloom Kidney Test, a new tool that can be integrated with the Bloom Smart System. The Bloom Kidney Test is a diagnostic tool that assesses kidney health by measuring cystatin C levels, which is a reliable indicator of kidney function. It classifies kidney function into three categories: normal, mildly decreased, and decreased. The Bloom Smart System leverages cloud-based algorithms and AI (artificial intelligence) technology to integrate test results with other relevant health information, such as medical history, lifestyle, and symptoms of the patient.

Product Innovations In The Diabetic Kidney Disease Market

Major companies operating in the diabetic kidney disease market are developing innovative products such as medications for chronic kidney disease (CKD) to meet larger customer bases, more sales, and increase revenue. Medication for chronic kidney disease (CKD) typically aims to manage symptoms, slow the progression of the disease, and address complications associated with impaired kidney function. For instance, in August 2022, Bayer AG, a Germany-based pharmaceutical company, launched Kerendia, a medication designed for managing chronic kidney disease (CKD) related to diabetes. As a distinctive characteristic, this medication is a non-steroidal, selective mineralocorticoid receptor antagonist specifically designated for individuals experiencing chronic kidney disease linked to type-II diabetes. Kerendia introduces a novel treatment paradigm, presenting a valuable approach to decelerate the advancement of chronic kidney disease and diminish the likelihood of kidney failure in this susceptible patient population.

AstraZeneca Acquired Cincor Pharma Inc

In January 2023, AstraZeneca, a UK-based biotechnology, and pharmaceutical company, acquired Cincor Pharma Inc., for an undisclosed amount. This acquisition will bolster AstraZeneca’s cardiorenal pipeline by adding CinCor’s candidate drug, baxdrostat (CIN-107), an aldosterone synthase inhibitor (ASI) for blood pressure lowering in treatment-resistant hypertension. CinCor Pharma Inc. is a US-based biopharmaceutical company specializing in the development of drugs for the management of kidney disease.

North America was the largest region in the diabetic kidney disease market in 2023. The regions covered in the diabetic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the diabetic kidney disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetic kidney disease market includes revenues earned by entities by providing diabetic kidney disease treatments for kidney stones, kidney infection, polycystic kidney disease, and kidney cysts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The diabetic kidney disease market research report is one of a series of new reports from The Business Research Company that provides diabetic kidney disease market statistics, including global market size, regional shares, competitors with a diabetic kidney disease market share, detailed diabetic kidney disease market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic kidney disease industry. This diabetic kidney disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Diabetic Kidney Disease Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.65 billion
Revenue Forecast In 2033 $3.29 billion
Growth Rate CAGR of 5.5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Type 1 Diabetes, Type 2 Diabetes
2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments
3) By End User: Hospitals, Homecare, Specialty Centers, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled AstraZeneca plc; Pfizer Inc.; Novartis AG; Bayer AG; Sanofi SA; Teva Pharmaceutical Industries Ltd.; Bristol-Myers Squibb Company; Sun Pharmaceutical Industries Ltd.; Mylan NV; Aurobindo Pharma Ltd.; Fresenius SE & Co. KGaA; F. Hoffmann-La Roche AG; Abbott Laboratories; Reata Pharmaceuticals Inc.; Merck & Co.; Mitsubishi Tanabe Pharma Corporation; Johnson & Johnson pvt. Ltd.; Eli Lilly and Company; Allergan Inc.; Endo International Inc.; GlaxoSmithKline plc; Hebei Changshan Biochemical Pharmaceutical Co. Ltd.; Hikma Pharmaceuticals plc; Fresenius Kabi AG; AbbVie Inc.; Boehringer Ingelheim International GmbH; Chugai Pharmaceutical Co. Ltd.; Daiichi Sankyo Company Limited; Eisai Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Diabetic Kidney Disease Market Characteristics

    3. Diabetic Kidney Disease Market Trends And Strategies

    4. Diabetic Kidney Disease Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Diabetic Kidney Disease Market Size and Growth

    5.1. Global Diabetic Kidney Disease Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Diabetic Kidney Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Diabetic Kidney Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Diabetic Kidney Disease Market Segmentation

    6.1. Global Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Type 1 Diabetes

    Type 2 Diabetes

    6.2. Global Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Angiotensin Receptor Blockers (Arbs)

    Angiotensin-Converting Enzyme (Ace) Inhibitors

    Antioxidant Inflammation Modulator

    Calcium Channel Blockers

    Other Treatments

    6.3. Global Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Homecare

    Speciality Centres

    Other End Users

    7. Diabetic Kidney Disease Market Regional And Country Analysis

    7.1. Global Diabetic Kidney Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Diabetic Kidney Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Diabetic Kidney Disease Market  

    8.1. Asia-Pacific Diabetic Kidney Disease Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Diabetic Kidney Disease Market  

    9.1. China Diabetic Kidney Disease Market Overview  

    9.2. China Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Diabetic Kidney Disease Market  

    10.1. India Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Diabetic Kidney Disease Market  

    11.1. Japan Diabetic Kidney Disease Market Overview  

    11.2. Japan Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Diabetic Kidney Disease Market  

    12.1. Australia Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Diabetic Kidney Disease Market  

    13.1. Indonesia Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Diabetic Kidney Disease Market  

    14.1. South Korea Diabetic Kidney Disease Market Overview  

    14.2. South Korea Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Diabetic Kidney Disease Market  

    15.1. Western Europe Diabetic Kidney Disease Market Overview

    15.2. Western Europe Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Diabetic Kidney Disease Market  

    16.1. UK Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Diabetic Kidney Disease Market  

    17.1. Germany Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Diabetic Kidney Disease Market  

    18.5. France Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Diabetic Kidney Disease Market  

    19.9. Italy Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Diabetic Kidney Disease Market  

    20.13. Spain Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Diabetic Kidney Disease Market  

    21.1. Eastern Europe Diabetic Kidney Disease Market Overview

    21.2. Eastern Europe Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Diabetic Kidney Disease Market  

    22.1. Russia Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Diabetic Kidney Disease Market  

    23.1. North America Diabetic Kidney Disease Market Overview

    23.2. North America Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Diabetic Kidney Disease Market  

    24.1. USA Diabetic Kidney Disease Market Overview

    24.2. USA Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Diabetic Kidney Disease Market  

    25.1. Canada Diabetic Kidney Disease Market Overview

    25.2. Canada Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Diabetic Kidney Disease Market  

    26.1. South America Diabetic Kidney Disease Market Overview

    26.2. South America Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Diabetic Kidney Disease Market  

    27.1. Brazil Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Diabetic Kidney Disease Market  

    28.1. Middle East Diabetic Kidney Disease Market Overview

    28.2. Middle East Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Diabetic Kidney Disease Market  

    29.1. Africa Diabetic Kidney Disease Market Overview

    29.2. Africa Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Diabetic Kidney Disease Market Competitive Landscape And Company Profiles

    30.1. Diabetic Kidney Disease Market Competitive Landscape

    30.2. Diabetic Kidney Disease Market Company Profiles

    30.2.1. AstraZeneca plc

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Pfizer Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Novartis AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Bayer AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Sanofi SA

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Diabetic Kidney Disease Market Competitive Benchmarking

    32. Global Diabetic Kidney Disease Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Diabetic Kidney Disease Market

    34. Diabetic Kidney Disease Market Future Outlook and Potential Analysis

    34.1 Diabetic Kidney Disease Market In 2028 - Countries Offering Most New Opportunities

    34.2 Diabetic Kidney Disease Market In 2028 - Segments Offering Most New Opportunities

    34.3 Diabetic Kidney Disease Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Diabetic Kidney Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Diabetic Kidney Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: AstraZeneca plc Financial Performance
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Novartis AG Financial Performance
  • Table 77: Bayer AG Financial Performance
  • Table 78: Sanofi SA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Diabetic Kidney Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Diabetic Kidney Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: AstraZeneca plc Financial Performance
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Novartis AG Financial Performance
  • Figure 77: Bayer AG Financial Performance
  • Figure 78: Sanofi SA Financial Performance
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
Self-Service Technologies Global Market Report 2024 – By Type (ATM, Kiosks, Vending Machine), By Component (Hardware, Software, Services), By End-User (BFSI, Manufacturing, Hospitality, Retail, Healthcare, Offices, Education, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Customer Journey Analytics Global Market Report 2024 – By Component (Solution, Services), By Organization Size (Large Enterprises, Small and Medium-sized Enterprises (SMEs)), By Data Source (Web, Social Media, Mobile, Email, Store, Call Center, Other Data Sources), By Application (Customer Segmentation and Targeting, Customer Behavioral Analysis, Customer Churn Analysis, Brand Management, Campaign Management, Product Management, Other Applications), By Industry Vertical (BFSI, IT And Telecom, Healthcare, Retail And eCommerce, Government And Defense, Media And Entertainment, Manufacturing, Other Industry Verticals) – Market Size, Trends, And Global Forecast 2024-2033
View Report
C-Arms Global Market Report 2024 – By Type (Fixed C-Arms, Mobile C-Arms), By Detector (Image Intensifier, Flat Panel Detector), By Application (Cardiology, Gastroenterology, Neurology, Orthopedics And Trauma, Oncology, Other Applications), By End User (Hospital, Diagnostic Centers, Specialty Clinics, Other End-Users ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Surface Mining Global Market Report 2024 – By Type (Strip Mining, Open Pit Mining, Terrace Mining, Other Types), By Mineral (Metallic Ore, Non-Metallic Ore, Coal Mining), By End User (Metal, Electric Power Industry, Manufacturing, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Services Global Market Report 2024 – By Type (Civic Services, Real Estate, Leasing, Commercial Services, Personal Services, Repair and Maintenance), By Component (Hardware, Software, Service), By Mode (Online, Offline) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Analytical Laboratory Instrument Global Market Report 2024 – By Type (Element Analysis, Separation Analysis, Molecular Analysis, Other Types), By Application (Research, Clinical, Diagnostic, Other Applications), By End-User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Biotechnology, Other End-users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Analytical Standards Global Market Report 2024 – By Type (Organic Standards, Inorganic Standards), By Technique (Chromatography, Spectroscopy, Titrimetry, Physical Property Testing), By Application (Bioanalytical Testing, Stability Testing, Raw Material Testing, Dissolution Testing, Microbiology Testing, Physical Properties Testing, Toxicity Testing, Contamination Testing, QA/QC Testing, Proficiency Testing, Other Applications.), By End User (Food And Beverages Standards, Forensic Standards, Veterinary Drug Standards, Petrochemistry Standards, Environmental, Pharmaceutical And Life Science Standards, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2024 – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By End User (Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the diabetic kidney disease market?

Diabetic kidney disease refers to a type of renal disease driven by complications of diabetes that occurs when high levels of blood sugar cause damage to the kidneys. The blood vessels in the kidneys can become affected by high blood glucose, which ultimately reduces their functionality. For further insights on the diabetic kidney disease market, request a sample here

How will the diabetic kidney disease market drivers and restraints affect the diabetic kidney disease market dynamics? What forces will shape the diabetic kidney disease industry going forward?

The diabetic kidney disease market major growth driver - the soaring prevalence of chronic kidney disease propelling growth in the diabetic kidney disease market. For further insights on the diabetic kidney disease market, request a sample here

What is the forecast market size or the forecast market value of the diabetic kidney disease market ?

The diabetic kidney disease market size has grown strongly in recent years. It will grow from $2.51 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to early understanding of diabetes complications, advancements in diagnostic techniques, development of ace inhibitors and arbs, clinical trials and treatment protocols, guidelines and disease management protocols.. The diabetic kidney disease market size is expected to see strong growth in the next few years. It will grow to $3.29 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to personalized medicine and biomarker development, rising global diabetes incidence, focus on disease modification therapies, telehealth and remote care, healthcare policy and reimbursement changes.. Major trends in the forecast period include advancements in renal replacement therapies, precision medicine approach, focus on early detection and diagnosis, therapeutic advancements, rise in comorbidities management.. For further insights on the diabetic kidney disease market, request a sample here

How is the diabetic kidney disease market segmented?

The diabetic kidney disease market is segmented
1) By Type: Type 1 Diabetes, Type 2 Diabetes
2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments
3) By End User: Hospitals, Homecare, Speciality Centres, Other End UsersFor further insights on the diabetic kidney disease market, request a sample here

Which region has the largest share of the diabetic kidney disease market? What are the other regions covered in the report?

North America was the largest region in the diabetic kidney disease market in 2023. The regions covered in the diabetic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the diabetic kidney disease market, request a sample here.

Who are the major players in the diabetic kidney disease market?

Major companies operating in the diabetic kidney disease market report are AstraZeneca plc, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson pvt. Ltd., Eli Lilly and Company, Allergan Inc., Endo International Inc., GlaxoSmithKline plc, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals plc, Fresenius Kabi AG, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd. . For further insights on the diabetic kidney disease market, request a sample here.

What are the key trends in the diabetic kidney disease market?

Major trend in the diabetic kidney disease market - technological advancements reshaping the landscape of the diabetic kidney disease market. For further insights on the diabetic kidney disease market, request a sample here.

What are the major opportunities in the diabetic kidney disease market? What are the strategies for the diabetic kidney disease market?

For detailed insights on the major opportunities and strategies in the diabetic kidney disease market, request a sample here.

How does the diabetic kidney disease market relate to the overall economy and other similar markets?

For detailed insights on diabetic kidney disease market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the diabetic kidney disease industry?

For detailed insights on the mergers and acquisitions in the diabetic kidney disease industry, request a sample here.

What are the key dynamics influencing the diabetic kidney disease market growth? SWOT analysis of the diabetic kidney disease market.

For detailed insights on the key dynamics influencing the diabetic kidney disease market growth and SWOT analysis of the diabetic kidney disease industry, request a sample here.